Table 2.
Association between the clinicopathological characteristics and HNRNPA2B1 expression in 38 OSCC patients.
| Variables | No. | HNRNPA2B1 expression | ||
|---|---|---|---|---|
| Negative (n) | Positive (n) | p | ||
| Gender | 0.896 | |||
| Male | 29 | 9 | 20 | |
| Female | 9 | 3 | 6 | |
| Age (years) | 0.938 | |||
| <60 | 25 | 8 | 17 | |
| >=60 | 13 | 4 | 9 | |
| Smoking | 0.852 | |||
| Yes | 23 | 7 | 16 | |
| No | 15 | 5 | 10 | |
| Drinking | 0.825 | |||
| Yes | 20 | 6 | 14 | |
| No | 18 | 6 | 12 | |
| T classification | 0.031* | |||
| III–IV | 16 | 2 | 14 | |
| I–II | 22 | 10 | 12 | |
| Clinical stage | 0.896 | |||
| 1+2 | 9 | 3 | 6 | |
| 3+4 | 29 | 9 | 20 | |
| Histological grade | 0.036* | |||
| Poor | 12 | 1 | 11 | |
| Well-moderate | 26 | 11 | 15 | |
| Metastasis | ||||
| + | 24 | 4 | 20 | 0.01** |
| - | 14 | 8 | 6 | |
Metastasis refers to at least one lymph node metastasis or local or distant metastasis; * and ** indicated p<0.05 and p<0.01, respectively.